芪参还五胶囊联合羟乙基淀粉130/0.4对后循环缺血性眩晕患者心率、平均动脉压、氧分压的影响
2018-09-10郑建彪郑娜王雯黄静赵娜郝有志张万辉
郑建彪 郑娜 王雯 黄静 赵娜 郝有志 张万辉
摘要 目的:探討芪参还五胶囊联合羟乙基淀粉130/0.4对后循环缺血性眩晕(PCIV)患者心率(HR)、平均动脉压(MAP)、氧分压(PaO2)的影响。方法:选取2015年4月至2016年9月接受治疗的PCIV患者120例。按照随机数字表法均分为观察组和对照组,每组60例。对照组予以羟乙基淀粉130/0.4治疗,观察组则予以芪参还五胶囊联合羟乙基淀粉130/0.4治疗。分别比较2组疗效,治疗后HR、MAP、PaO2水平,治疗前后眩晕症状改善情况以及平均血流速度(VM)变化情况。结果:治疗后观察组总有效率为95.00%(57/60),高于对照组的81.67%(49/60)(P<0.05)。治疗后观察组HR、MAP、PaO2水平分别为(76.6±11.3)次/min、(91.2±10.4)mmHg、(81.4±12.6)mmHg,均高于对照组的(68.9±12.6)次/min、(81.7±11.5)mmHg、(73.2±12.8)mmHg,差异有统计学意义(P<0.05)。治疗后2组DHI评分均低于治疗前,而观察组又低于对照组,差异有统计学意义(P<0.05)。治疗后观察组左侧椎动脉VM、右侧椎动脉VM、基底动脉VM均高于对照组,差异有统计学意义(P<0.05)。结论:芪参还五胶囊联合羟乙基淀粉130/0.4治疗PCIV的疗效显著,且能有效维持患者生命体征稳定,减轻疾病对患者造成的影响,同时有效改善患者血流动学指标水平。
关键词 后循环缺血;眩晕;疗效;芪参还五胶囊;血流动力学
Abstract Objective:To study the effects of Qishen Huanwu Capsules combined with hydroxyethyl starch 130/0.4 on heart rate (HR), mean arterial pressure (MAP) and oxygen partial pressure for patients with posterior circulation ischemic vertigo (PCIV). Methods:A total of 120 cases of patients with PCIV were admitted and treated in Cangzhou Hospital of Integrated Chinese and Western Medicine from April 2015 to September 2016. According to random number table method, patients were divided into observation group (60 cases) and control group (60 cases). Patients in control group were treated with hydroxyethyl starch 130/0.4 and patients in observation group were treated with Qishen Huanwu Capsules on the basis of that in control group. Curative effects of the two groups were respectively compared after treatment--heart rate (HR), mean arterial pressure (MAP), oxygen partial pressure (PaO2) levels, the improvement of vertigo symptom before and after treatment as well as the change of the mean flow velocity (VM). Results:The total effective rate of the treatment group was 95.00% (57/60), which was higher than that of control group 81.67% (49/60) (P<0.05). HR, MAP, PaO2 levels in observation group after treatment were respectively (76.6±11.3) times/min, (91.2±10.4) mmHg and (81.4±12.6) mmHg, which were higher than those in control group (68.9±12.6) times/min, (81.7±11.5) mmHg, (73.2±12.8) mmHg, and had significant difference (P<0.05). DHI scores after treatment in two groups were lower than those before the treatment and the observation group were lower than those in control group, which had significant differences (P<0.05). After treatment, the left side of the vertebral artery VM, the right side of the vertebral artery VM and the basal artery VM in treatment group were higher than those in control group, with significant differences (P<0.05). Conclusion:Qishen Huanwu Capsules combined with hydroxyethyl starch 130/0.4 had significant effects on PCIV and can effectively maintain stable vital signs, decrease the effects of disease of patients and effectively improve the patients′ blood rheology indexes.
Key Words Posterior circulation ischemia; Vertigo; Curative effect; Qishen Huanwu Capsules; Hemodynamics
中图分类号:R289.5文献标识码:Adoi:10.3969/j.issn.1673-7202.2018.02.021
循环缺血性眩晕(Posterior Circulation Ischemia Vertigo,PCIV)属于后循环缺血患者的临床表现症状之一[1]。近年来,随着我国老年人数量的逐渐增加,后循环缺血的发病率也呈逐年上升趋势,而PCIV亦成为目前临床上研究的热点[2]。且有研究报道显示,PCIV患者具有较高的致残率以及病死率,严重影响了患者的生命健康安全[3]。因此,我们研究芪参还五胶囊联合羟乙基淀粉130/0.4对后循环缺血性眩晕(PCIV)患者心率(HR)、平均动脉压(MAP)、氧分压(PaO2)的影响,目的在于为临床有效治疗PCIV提供参考依据,现报道如下。
1 资料与方法
1.1 一般资料 选取2015年4月至2016年9月于我院接受治疗的PCIV患者120例。按照随机数字表法均分为观察组和对照组,每组60例。观察组中男39例,女21例,年龄52~79岁,平均年龄(63.4±5.8)岁。对照组中男37例,女21例,年龄53~79岁,平均年龄(63.3±5.6)岁。2组患者年龄与性别等资料比较,差异无统计学意义(P>0.05),具有可比性。本……
